The Asia Pacific Advocates for Tobacco Harm Reduction Alliance (CAPHRA) has written letters to the heads of various tobacco-control framework convention delegations urging them to review evidence supporting tobacco harm reduction (THR) methods before COP10.
As governments from around the world send delegates to COP10 in November 2023, CAPHRA is eager to provide comprehensive reference materials to leaders for their planning, submission writing, and review processes.
The 10th Conference of Parties (COP10) will be held in Panama and will be hosted by the World Health Organization's Framework Convention on Tobacco Control.
We, on behalf of the 4 million users in the Asia-Pacific region who currently utilize safer nicotine products, are taking this action. As you may be aware, our region is particularly vulnerable to the harm and deaths caused by combustible and unsafe oral tobacco.
Representatives from CAPHRA have reminded healthcare leaders that the FCTC has the authority to make harm reduction a core tobacco control policy.
For decades, it has been widely accepted that tar and carcinogenic substances found in tobacco smoke are responsible for smoking-related deaths and illnesses, rather than nicotine. Studies have shown that while nicotine can be mildly addictive, similar to caffeine, it is not a health concern, according to the authors.
The letter also calls on representatives to condemn the policy of holding the COP10 conference of the FCTC behind closed doors.
Representatives attending COP10 are expected to represent the rights and wishes of their citizens, whose taxes are funding their attendance. Citizens expect their representatives to speak on their behalf, recognize the scientific support for reducing harm through ENDS, and uphold democratic principles, the letter stated.
CAPHRA representatives are calling on countries to consider consumers' right to make choices that can help them avoid negative health outcomes when submitting their COP10 statements. It is crucial that smokers have access to nicotine products with less harmful effects as alternatives to smoking.
At the fifth Asia Harm Reduction Forum, CAPHRA's executive coordinator Nancy Loucas presented a recently released white paper titled "Disrupting Public Health: A Consumer Perspective," which is based on evidence.
2FIRSTS will continue to cover this topic and provide updates on our mobile application, '2FIRSTSAPP.' Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
